Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics-Reference-Cited by-同舟云学术

Rearranging the domain order of a diabody-based IgG-like bispecific antibody enhances its antitumor activity and improves its degradation resistance and pharmacokinetics

Published:2014-09-03 Issue:5 Volume:6 Page:1243-1254
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Asano Ryutaro,Shimomura Ippei,Konno Shota,Ito Akiko,Masakari Yosuke,Orimo Ryota,Taki Shintaro,Arai Kyoko,Ogata Hiromi,Okada Mai,Furumoto Shozo,Onitsuka Masayoshi,Omasa Takeshi,Hayashi Hiroki,Katayose Yu,Unno Michiaki,Kudo Toshio,Umetsu Mitsuo,Kumagai Izumi

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.4161/mabs.29445

Reference36 articles.

1. A tale of two specificities: bispecific antibodies for therapeutic and diagnostic applications

2. Bispecific antibodies for cancer therapy

3. Diabodies: small bispecific antibody fragments

4. Biodistribution of a Bispecific Single-chain Diabody and Its Half-life Extended Derivatives

5. Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incorporation of a repeated polypeptide sequence in therapeutic antibodies as a universal masking procedure: A case study of T cell-engaging bispecific antibodies;New Biotechnology;2023-11

2. Cancer therapeutic trispecific antibodies recruiting both T and natural killer cells to cancer cells;Oncology Reports;2023-10-20

3. Functional integration of protein A binding ability to antibody fragments for convenient and tag-free purification;Bioengineered;2023-09-21

4. High-Throughput and Format-Agnostic Mispairing Assay for Multispecific Antibodies Using Intact Mass Spectrometry;Analytical Chemistry;2023-06-27

5. T Cell Bispecific Antibodies: An Antibody-Based Delivery System for Inducing Antitumor Immunity;Pharmaceuticals;2021-11-17